MTVA: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, MTVA has $14,388K in assets. $5,315K in debts. $13,731K in cash and cash equivalents.

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	13,731	10,278	14,277	17,589
Prepaid expenses and other current assets	431	597	369	726
Total current assets	14,162	10,875	14,646	18,315
Property and equipment, net	12	17	22	27
Right-of-use asset	193	210	76	96
Other assets	21	21	21	21
Total assets	14,388	11,123	14,765	18,459

Accounts payable	1,007	1,060	2,599	2,875
Clinical trial accrued liabilities	627	79	1,562	1,463
Accrued expenses and other current liabilities	456	993	711	610
Warrant liabilities	19	136	167	114
Related party payable	3,012	3,312	3,316	3,675
Lease liability, short-term	71	68	79	83
Total current liabilities	5,192	5,648	8,434	8,820
Lease liability, long-term	123	142	-	15
Total liabilities	5,315	5,790	8,434	8,835
Common stock, 0.001 par value per share, 100,000,000 shares authorized as of march 31, 2026 and december 31, 2025 5,164,370 and 2,308,294 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively	5	2	24	24
Additional paid-in capital	161,721	154,161	153,207	153,123
Accumulated deficit	-152,653	-148,830	-146,900	-143,523
Total stockholders' equity	9,073	5,333	6,331	9,624
Total liabilities and stockholders' equity	14,388	11,123	14,765	18,459

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.